Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends approval for Rixubis in patients with hemophilia B

Oct. 28, 2014

CHMP recommends approval of Duavive

Oct. 28, 2014

EMA recommends that Clinuvel's Scenesse be approved for EPP

Oct. 27, 2014

EMA committee backs approval of olaparib in BRCA-mutated ovarian cancer

Oct. 27, 2014

CHMP recommends expanding approval of enzalutamide

Oct. 27, 2014

CHMP adopts positive opinion for oxycodone/naloxone in RLS

Oct. 27, 2014

EMA outlines recent efforts to expedite development of Ebola treatments

Oct. 23, 2014

EMA grants orphan drug designation to Epidiolex for Dravet syndrome

Oct. 22, 2014

EMA grants orphan drug designation to isactuzumab govitecan

Oct. 21, 2014

Lymphoseek recommended by CHMP for sentinel lymph node detection

Sep. 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...